The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Nope, I'm not buying. Are you serious? LOL
My mistake, £2K of total buys now reported across AIM market. No one is buying....
So here we go again... It's almost like some posters have an incentive to post & get replies. LOL. But surely not on AIMs.
£1K of shares bought today... there is no one to ramp . So who's on the ramp shift tonight? Let's chat.....
JohnneyK hit the nail on the head. It doesn't matter which countries are open or not, consumer confidence was knocked hugely when Spain was put on the 'naughty' list. I work in the industry and it's put us back to covid square one. Summer 2020 season is nearly done & all travel companies now need to conserve cash for a bounce back in 2021... such a great buying opportunity at this range to put in the bottom draw for a large profit mid/end next year.
Some key points taken from my notes:
LG Chem partnership
- Next generation chemo therapy only targets cancerous cells. Reduces side effects.
- 60% of lab tests showed 100% regression on tumours with future immunity.
- Deal worth £310M if clinically successful + royalty payments
Daewoong Joint Venture (South Korea)
- Avacta hold 45%. Comparable businesses in USA sold for US$1Billion pre-clinical trials.
Affirmer Platform
- 30 custom partnerships/evaluations ongoing. 100% success rate.
- Multiple repeat customers. Has licensing agreements in pipeline.
Diagnostics Division
- 5 main areas of developments addressing gaps in large markets (includes COVID-19)
COVID-19
- Companies who are developing PCR/Antibody tests on rabbit/mice are struggling to get required results due to complexity of COVID-19.
- Avacta owns all rights. At our discrection on how it is used with which partners.
- Will be working with more partners as Cytiva CANNOT supply the demand needed. More partners to be announced.
Questions
What is the cost to produce the test?
- Used the example of the consumer HIV self test. Typically costs $30 retail and $2 to produce.
- That's the margin you (shareholders) should use as an example but nothing decided yet.
How confident are you that COVID-19 will work?
- We are very confident the test will work. The regulatory process is just a process. No risks.
- The technical risks have already been overcome.
Are partners able to sell your tests/technology themselves?
- We own all rights. Partners will be licensed with royalty agreements or on a purely manufacturing basis producing tests under our name.
Will there be future share placing before COVID test human trials?
- No intention/no plan for future share placing before COVID human testing complete.
- Fully funded to 2022.
- Substantial near-term news flow anticipated.
TUI's share price lows may be tested again unless the UK government pulls their head out of their aaaarse and changes the Package Travel Regulations. With current law, when TUI cancels their current bookings for the rest of May & June (which they will need to do) they will need to issue refunds within 14 days. May & June must be around 1-1.5 billion euros revenue which will cause massive cash flow issues...
IMO this is why TUI hasn't cancelled past mid-May...
IMHO the Summer 2020 season is pretty much written off. Still can't understand why the industry, TUI included, has only cancelled holidays up to 14 May. That's only 4 weeks away!!! No one is going to be jetting off to Italy, Spain, Portugal etc for many months at least. The industry has a huge problem at the moment with this - many have furloughed the majority of office staff so who is going to manage those thousands of cancellations for end May, June onwards departures....
My take on this is to wait until June/July before buying in. All in my opinion of course but have many years in the industry and this is going to be a long recovery.
Points to consider:
Travel bans: Countries will remove lock-down/social distancing but it will be longer before they open up to accepting international tourist flights.
Customer Confidence: Once people have the option to fly it will take time for confidence to return. After the SARS outbreak it took a good 6-8 months for bookings to return to pre-SARS level. This will be longer for COVID. Search for "travel industry recovery after SARS" - lots of good research articles online.
Brand Trust : Most travel companies are not issuing refunds for monies paid but credit vouchers. Jet2 are issuing refunds in full and TUI has gone down the credit voucher route. Those issuing vouchers are having their brands trashed online and are losing valuable customers. Consumers will remember this when it comes to booking for next year.
Supply chain : TUI may be OK as they have 'operator owned' resorts but many local suppliers will not be in business once this is over. eg. smaller hotels/resorts, coach operators, local guides/reps, activity providers etc. It will take time for new/existing local companies to start up, re-hire and upscale to demand.
TUI will get through this due to their size but in what shape will they be in?
There's been lots of talk about EVRH being at risk due to the amount of people adopting VR. I think it works the other way. It's the content available that drives the uptake. If your fave band is performing live and streamed via Melody, that's an incentive to get VR connected, That's why Sky bought the rights to F1, Football etc. If there is a passionate audience who wants to watch the content, you're more than halfway there to sell the platform.
I'm in with first purchase today albeit a small toe in the water... Have a large chunk in HUM so top slices coming in here when the market finally sees HUM's value to balance investment. When CORA releases good news it's a win/win position :-)
Not too bad. Shame they are selling Travelopia though. Some good specialist travel companies in there... a few I have travelled with. A case of a huge plc not wanting to support it's smaller brands maybe?
Nice bounce. Re-structuring at mo and future looks good from where I am sitting...